PranaX is a regenerative biological products company dedicated to harnessing stem cell-derived exosomes through evidence-based science. We aim to develop exosomes as natural, physician-directed solutions for regenerative dermatology and wellness applications. The company’s overarching mission is to unlock the properties of exosomes to promote wellness and lead individuals towards healthier, more fulfilling lives.
Our exosomes at a glance:
• We use an exclusive technology license from MD Anderson, a leading-edge cancer research center known as a premier provider of exosome-driven therapy.
• Production takes place at our own FDA-registered, GMP facility.
• Leveraging multiple licensed patents allows us to develop anti-aging therapeutics.
• Because we manufacture our stem cell exosomes, we can manage quality assurance and replenish supply to meet demand.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Houston, Texas, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://pranax.com
- Keywords
- Biotechnology Research.
- HQ
- Houston, Texas
Pranax Questions
Pranax's website is https://pranax.com
Pranax's LinkedIn profile is https://www.linkedin.com/company/pranax
Pranax has
9 employees.
View email and phone details for 9
employees at Pranax.
Pranax's industry is
Biotechnology Research
Pranax's top competitors are
Quva,
Catalyst Life Sciences,
Lonza,
Wilcrest Pharma,
Ctmc,
Cellipont Bioservices,
Immatics,
Neurogene Inc.,
Kiromic Biopharma, Inc.,
Sino Biological, Inc..
Pranax's categories are Biotechnology Research
Pranax's founding year is 2022
